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l-(+)-Furanomycin (1) (Scheme 1) is a naturally occurring 
cyclic -alkoxy -amino acid isolated by Katagiri from the 
fermentation broth of Streptomyces L-803(ATCC15795).
1
 The 
original report detailed that 1 significantly suppressed the growth 
of several bacterial species including strains of Escherichia coli, 
Bacillus subtilis, Shigella paradysenteriae, Salmonella paratyphi 
and Mycobacterium tuberculosis. A later report demonstrated 
that 1 acts as a substrate of isoleucyl aminoacyl tRNA synthetase 
(AARSIle) with in vitro replacement of isoleucine during protein 
translation.
2
  
 
 
Scheme 1. Furanomycin 1 and Retrosynthetic Analysis. 
 
Although 1 does not offer exceptional molecular complexity, 
the antibiotic activity and the compact nature of furanomycin has 
meant that significant synthetic attention has been paid as a 
vehicle for assessing new methodologies.
3,4 
 
We have recently reported the Ireland-Claisen [3,3]-
sigmatropic rearrangement of glycinates
5
 containing allylic enol 
ether units as part of a larger research programme into new 
applications of the Ireland-Claisen rearrangement.
6
 After 
rearrangement of these glycinates, functionalized syn--alkoxy 
-amino acids are formed with high levels of stereocontrol. The 
inherent syn--alkoxy -amino acid structure embedded within 
furanomycin suggested 1 as a clear target for this Ireland-Claisen 
methodology. 
A retrosynthetic analysis of 1 lent itself to a late-stage ring-
closing diene metathesis approach to form the dihydrofuran ring 
from a suitable dienyl syn--alkoxy -amino ester (Scheme 1). 
Diene 2 would in turn be accessed from an Ireland-Claisen 
rearrangement of glycinate 3.
7
 Key allylic alcohol 4 should be 
formed through a reduction of -alkoxy acrylate 6, with the 
ultimate introduction of chirality stemming from enantiopure 
allylic alcohol 8 (Scheme 1).
8
 
The retrosynthetic strategy described in Scheme 1 asks two 
key questions. Firstly, we were unaware of the use of a chiral 
allyl vinyl ether, such as that present in 3, which would act as a 
remote exopericyclic stereocontrol element in an Ireland-Claisen 
rearrangement. Secondly, the silylketene acetal formed from 
glycinate 3 would bear two allyl vinyl ether fragments that could 
offer competing rearrangement (Figure 1). We were confident of 
chemoselective rearrangement based on our previous work on a 
simpler O-allyl enol ether.
5b
 However, the relative stereocontrol 
offered by this exopericyclic stereocentre was not as clear-cut and 
therefore offered an interesting methodological problem which 
could be answered through this attempted total synthesis. 
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Figure 1. Postulated Silylketene Acetal Required for Rearrangement. 
 
Our synthesis commenced with the construction of the 
requisite glycinate 3 (Scheme 2). Oxy-Michael reaction of allylic 
alcohol 8 to methyl propiolate, catalysed by DABCO, formed 
vinylogous carbonate 6 in 60% yield. DIBAL-H mediated 
reduction of the ester moiety (80%) and rapid EDCI mediated 
coupling of 5 with di-Boc-glycine formed 3 in excellent yield 
(98%). 
 
 
 
Scheme 2. Synthesis of Rearrangement Substrate 3. 
 
Application of the rearrangement protocol previously 
optimized for these di-Boc glycinate substrates
5b
 resulted in 
smooth rearrangement, which after acid methylation, allowed 
isolation of syn--alkoxy -amino ester 2 (Scheme 3). Two 
inseparable diastereomers were isolated from this reaction in a 
ratio of anti,syn/syn,syn = 72:28, with the major anti,syn-
diastereomer displayed in Scheme 3. Efforts were made to 
improve the rearrangement selectivity by conducting the reaction 
at lower temperatures over extended periods of time. However, 
both reaction efficiency and selectivity were adversely affected. 
The levels of stereocontrol mirror the magnitude we reported for 
a structurally similar glycinate bearing a chiral enol ether derived 
from 1-phenylethanol.
5b 
The sense of selectivity is still consistent 
with the -facial selectivity proposed by Greene
9
 for chiral enol 
ethers in asymmetric dichloroketene [2+2]-cycloadditions and is 
depicted as transition state geometry I (Scheme 3). 
 
 
 
Scheme 3. Ireland-Claisen Rearrangement to Key Diallyl Ether 2. 
 
Our previous study with di-Boc glycinates demonstrated a 
comprehensively high level of syn-diastereoselectivity at the - 
and -stereocentres relative to the ester and this has been 
incorporated into our understanding in this instance. The sense of 
diastereocontrol relative to the original allylic stereocentre was 
assessed after ring formation (vide supra). Ring-closing 
metathesis
10
 using the first generation Grubbs Ru-catalyst 
occurred smoothly at room temperature (Scheme 4) and 
preserved the observed level of diastereocontrol. The sense of 
relative stereocontrol offered by the exopericyclic allylic 
stereocentre was determined through spectroscopic means with a 
pronounced NOE observable between the C(2) ring methine and 
the methyl group (II, Scheme 4). A similar NOE was not 
observed in the minor stereoisomer.  
Our original plan had been to effect ester hydrolysis prior to 
acidic removal of the two tert-butyl carbamate protecting groups, 
allowing convergence with the penultimate intermediate in 
Standaert’s efficient synthesis of furanomycin.
3d
 However, this 
saponification proved unmanageable (Scheme 4). A number of 
conditions were studied with the bases KOTMS, LiOH, NaOH, 
KOH and CsOH all examined. It is clear that 9 is consumed 
during the saponification, as evidenced by TLC reaction 
monitoring. However, intractable mixtures form as a result, 
further confirming the base sensitivity of these -alkoxy -amino 
esters previously seen with the acyclic rearrangement products.  
 
 
 
Scheme 4. Dihydrofuran Formation. 
 
Therefore, a decision was made to alter the synthetic strategy 
and proceed with a formal total synthesis. We had previously 
demonstrated that clean mono-Boc deprotection was possible 
with these compounds. This was indeed the case with 9, which 
was progressed to 11 on treatment with TFA. Subsequent 
LiAlH4-mediated ester reduction formed N-Boc furanomycinol 
12 which converged with the Standaert synthesis.
3d
 
Unfortunately, the mixture of diastereomers formed from the 
Ireland-Claisen rearrangement continued to be inseparable 
throughout the synthesis and therefore 12 was obtained as a 
72:28 mixture of diastereomers. 
 
 
 
Scheme 5. Completion of Formal Total Synthesis. 
 
In conclusion, the first Ireland-Claisen rearrangement of a 
substrate bearing a chiral allylic enol ether as a stereocontrol 
element is reported. A reasonable level of relative stereocontrol is 
observed on consideration of the remote nature of the controlling 
stereocentre. The rearrangement product has in turn been 
transformed to a late-stage intermediate from a recent synthesis 
of furanomycin and hence constitutes a rapid formal total 
synthesis of 1. 
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